57results about How to "Pharmacological effect is clear" patented technology

The invention provides a method for extracting Juema polysaccharides by ultrasonic-assisted degreasing. It takes Juema as raw material, adds petroleum ether, refluxes and degreases at different temperatures, evaporates the solvent, soaks and washes with ethanol at room temperature, adds distilled water, and transfers to ultrasonic Extraction equipment, ultrasonic extraction and filtration, collect the water extract, add water to the filter residue and ultrasonically extract twice, combine the water extract, concentrate by rotary evaporation, add papain enzymatic hydrolysis, take the supernatant after centrifugation, and filter with a micro-suction filter , further remove the finer filter residue, concentrate the collected filtrate, and then use a mixture of n-butanol and chloroform to extract 3 to 5 times, collect the upper aqueous phase, add ethanol to the aqueous phase, and centrifuge to collect the precipitate after standing, freeze Drying will give purified Bracken polysaccharide.

The invention discloses an ilicis routundae cortex medicinal composition for preventing and treating alcoholic liver damage, alcoholic fatty liver, non-alcoholic fatty liver and hyperlipidemia. The composition is extracted and refined from natural ilicis routundae cortex and is not chemically modified, and is characterized by comprising substances such as pedunculoside, syringin, rotundicacid andthe like. The invention also discloses a preparation method of the ilicis routundae cortex composition and application to preparation of a medicament for preventing and treating the alcoholic liver damage, the alcoholic fatty liver and the non-alcoholic fatty liver and lowering blood fat.

The invention discloses a Xuesaitong pharmaceutical composition, its preparation method, preparation and application. The Xuesaitong pharmaceutical composition includes the following pharmaceutical components in mass percentage: 0.001-99.996% of ginsenoside Rb2, 0.001-99.996% of ginsenoside Rb1, 0.001-99.996% of ginsenoside Rg1, 0.001-99.996% of ginsenoside Rc and Notoginsenoside R1 0.001~99.996%. The pharmaceutical composition of the present invention and its preparation are effective for myocardial infarction, cerebral apoplexy, cerebral infarction, cerebral hemiplegia and other ischemic cardiovascular and cerebrovascular diseases, as well as retinopathy or optic nerve damage caused by ischemic cardiovascular and cerebrovascular diseases, diabetes and other reasons. Significant curative effect, has broad application prospects. Compared with the prior art and products, the Xuesaitong medicinal composition and its preparations of the present invention have better curative effect and higher safety, and can better meet the requirements of clinical medication. The preparation method provided by the invention has simple process, mild conditions, convenient operation, stable and controllable quality, and is suitable for large-scale industrial production.